Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBunzl Regulatory News (BNZL)

Share Price Information for Bunzl (BNZL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,922.00
Bid: 2,928.00
Ask: 2,930.00
Change: -48.00 (-1.62%)
Spread: 2.00 (0.068%)
Open: 2,974.00
High: 2,974.00
Low: 2,918.00
Prev. Close: 2,970.00
BNZL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

19 Dec 2012 07:00

RNS Number : 8772T
Bunzl PLC
19 December 2012
 



 

 

19 December 2012

 

BUNZL PRE CLOSE STATEMENT

 

Bunzl plc, the international distribution and outsourcing Group, is updating the market today relating to the twelve months ending 31 December 2012 prior to entering its close period.

 

Overall trading has been consistent with expectations at the time of the Interim Management Statement in October. At constant exchange rates Group revenue growth for the year is expected to be approximately 6%, due to underlying revenue growth and the positive impact from acquisitions net of the disposal of the UK vending business in August 2011, with Group operating margin in line with the prior year. Underlying revenue growth for the year is expected to be about 2.5% against the background of a challenging comparative in the second half due to a particularly strong performance in North America last year.

 

Acquisition growth is a key element of the Group's growth strategy. Including the two acquisitions announced today of McCordick Glove and Atlas Health Care, the Company has announced nine acquisitions year to date with annualised revenue from 2012 acquisitions of approximately £210 million. The current environment for acquisitions remains positive.

 

The Group has recently refinanced some of its debt facilities by raising US$350 million of fixed interest rate borrowings in the US private placement market with maturities ranging from seven to 11 years at an average interest rate of 3.4%. US$110 million was drawn earlier this month with the balance due to be drawn in April 2013.

 

Bunzl's strong cash flow and balance sheet should continue to enable the Company to take advantage of opportunities to consolidate further the markets in which it competes and increase shareholder value.

 

Enquiries:

 

Bunzl plc

Michael Roney, Chief Executive

Brian May, Finance Director

Tel: 020 7725 5000

Tulchan

David Allchurch

Stephen Malthouse

Tel: 020 7353 4200

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGLBDDSXBBGDC
Date   Source Headline
3rd Jun 202411:15 amRNSTotal Voting Rights
28th May 20247:00 amRNSAcquisition
23rd May 20248:00 amRNSAdditional Listing
22nd May 20242:30 pmRNSHolding(s) in Company
7th May 20243:35 pmRNSDirector/PDMR Shareholding
7th May 202411:40 amRNSDirector/PDMR Shareholding
2nd May 20242:00 pmRNSDirector/PDMR Shareholding
2nd May 20248:00 amRNSAdditional Listing
1st May 20245:00 pmRNSDirector/PDMR Shareholding
1st May 202410:00 amRNSBlock listing Interim Review
1st May 20249:18 amRNSTotal Voting Rights
25th Apr 20244:45 pmRNSDirector/PDMR Shareholding
24th Apr 20242:51 pmRNSResult of AGM
24th Apr 20247:00 amRNSTrading Statement
22nd Apr 20244:36 pmRNSDirector/PDMR Shareholding
18th Apr 20248:00 amRNSAdditional Listing
11th Apr 20248:00 amRNSAdditional Listing
3rd Apr 20245:28 pmRNSDirector/PDMR Shareholding
3rd Apr 20249:09 amRNSDirector/PDMR Shareholding
2nd Apr 20241:50 pmRNSTotal Voting Rights
21st Mar 20248:00 amRNSAdditional Listing
15th Mar 20243:28 pmRNSAnnual Financial Report
7th Mar 20248:00 amRNSAdditional Listing
5th Mar 20245:05 pmRNSDirector/PDMR Shareholding
4th Mar 20243:03 pmRNSDirector/PDMR Shareholding
1st Mar 202411:35 amRNSTotal Voting Rights
28th Feb 20243:17 pmRNSDirector/PDMR Shareholding
27th Feb 20245:26 pmRNSDirector/PDMR Shareholding
26th Feb 202410:30 amRNSDividend Declaration
26th Feb 20247:00 amRNSFinal Results
26th Feb 20247:00 amRNSAcquisition
5th Feb 20242:20 pmRNSDirector/PDMR Shareholding
1st Feb 20245:08 pmRNSTotal Voting Rights
12th Jan 20244:54 pmRNSDirector/PDMR Shareholding
11th Jan 20243:50 pmRNSDirector/PDMR Shareholding
2nd Jan 202410:57 amRNSTotal Voting Rights
15th Dec 20235:10 pmRNSHolding(s) in Company
14th Dec 20237:00 amRNSTrading Statement
8th Dec 20235:32 pmRNSDirector/PDMR Shareholding
1st Dec 202311:32 amRNSTotal Voting Rights
20th Nov 20236:30 pmRNSPublication of Admission Particulars
3rd Nov 20239:30 amRNSDirector Declaration
2nd Nov 20232:29 pmRNSDirector/PDMR Shareholding
1st Nov 202311:24 amRNSTotal Voting Rights
1st Nov 20239:00 amRNSBlock listing Interim Review
24th Oct 20237:00 amRNSTrading Statement
6th Oct 20235:08 pmRNSDirector/PDMR Shareholding
4th Oct 20231:40 pmRNSDirector/PDMR Shareholding
2nd Oct 20231:34 pmRNSTotal Voting Rights
2nd Oct 20231:33 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.